军事知识服务平台
Ferumoxytol triggers cancer ferroptosis via an NF-κB-driven IRONKILL mechanism
摘要 Traditional radiotherapy and chemotherapy,despite killing tumor cells,often lack selectivity and therefore cause sub-stantial collateral damage in patients1.Moreover,the ability of some cancer cells to evade these treatments may lead to relapse and metastasis2.Since 2012,ferroptosis has been a rev-olutionary approach in cancer therapy.Ferroptosis is driven by an abnormal accumulation of intracellular iron ions,which catalyze the buildup of lipid peroxides and ultimately disrupt cellular integrity3.This mechanism challenges conventional paradigms and offers a new strategy to combat refractory tumors that are resistant to apoptosis and prone to drug resist-ance.Because ferroptosis is triggered by iron-dependent lipid peroxidation(lipROS),a key question is how to selectively increase iron levels in tumor cells4.
年,卷(期): 2026, 23(9)
机标分类号: R965.2 R-332 R743
在线出版日期: 2026年10月13日